Medpace Holdings, Inc. — Director's Dealing 2018

Aug 9, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2017-06-30

Reporting Person: Troendle August J. (Director, President & CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-30	Common Stock	J	27571	—	Disposed	9182547	Indirect
2017-07-31	Common Stock	J	37037	—	Disposed	9145510	Indirect
2018-08-07	Common Stock	S	138105	$57.06	Disposed	351851	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: Issuer shares were disposed of by Medpace Investors, LLC ("MPI) through an in-kind exchange of incentive units of MPI acquired by employees of entities affiliated with the Issuer.

F2: The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the shares held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

F3: Issuer shares were disposed of by MPI through an in-kind exchange of Class B units of MPI acquired by an individual.

F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2018.

F5: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.96 to $58.16. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.